CD33 Inhibitors

CD33 inhibitors are a class of chemical compounds designed to target and modulate the activity of the CD33 protein. CD33, also known as Siglec-3 (Sialic acid-binding immunoglobulin-type lectin 3), is a cell surface receptor primarily found on the surface of cells in the myeloid lineage, including myeloid stem cells and mature myeloid cells such as monocytes, macrophages, and granulocytes. This receptor plays a crucial role in regulating immune responses and is of particular interest in the context of hematopoiesis and immune system function. The CD33 protein is characterized by its ability to bind to sialic acid residues present on the surface of other cells. This interaction between CD33 and sialic acid serves as a regulatory mechanism to prevent excessive immune responses and maintain immune homeostasis. CD33 inhibitors, as their name suggests, interfere with the normal functioning of CD33 by modulating its binding capacity or downstream signaling pathways. By doing so, they have the ability to influence immune cell development, activation, and function.